Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 49, Issue -, Pages 20-26Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2017.08.004
Keywords
-
Categories
Funding
- INSERM, the French National Research Agency [ANR 12-BSV1-0020-01]
- Histiocytosis Association of America
- ANR grants
- Agence Nationale de la Recherche (ANR) [ANR-12-BSV1-0020] Funding Source: Agence Nationale de la Recherche (ANR)
Ask authors/readers for more resources
Hemophagocytic lymphohistiocytosis (HLH, also referred to a hemophagocytic syndrome) is a life-threatening condition in which uncontrolled activation of lymphocytes and macrophages, and thus the secretion of large amounts of inflammatory cytokines, leads to a severe hyperinflammatory state. Over the last few decades, researchers have characterized primary forms of HLH caused by genetic defects that impair lymphocytes' cytotoxic machinery. Other genetic causes of HLH not related to impaired cytotoxicity have also recently been identified. Furthermore, the so-called 'acquired' forms of HLH are encountered in the context of severe infections, autoimmune and autoinflammatory diseases, malignancy, and metabolic disorders, and may also be associated with primary immunodeficiencies. This implies that a variety of disease mechanisms can lead to HLH. Today's research seeks to gain a better understanding of the various pathogenetic and environmental factors that converge to induce HLH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available